GB1498913A - Magnesium-containing pharmaceutical compositions - Google Patents
Magnesium-containing pharmaceutical compositionsInfo
- Publication number
- GB1498913A GB1498913A GB6422/76A GB642276A GB1498913A GB 1498913 A GB1498913 A GB 1498913A GB 6422/76 A GB6422/76 A GB 6422/76A GB 642276 A GB642276 A GB 642276A GB 1498913 A GB1498913 A GB 1498913A
- Authority
- GB
- United Kingdom
- Prior art keywords
- magnesium
- compositions
- strontium
- chloride
- pharmaceutical compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229910052749 magnesium Inorganic materials 0.000 title abstract 3
- 239000011777 magnesium Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 abstract 2
- 229910052712 strontium Inorganic materials 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 206010014418 Electrolyte imbalance Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 206010061216 Infarction Diseases 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 208000024799 Thyroid disease Diseases 0.000 abstract 1
- 229910001508 alkali metal halide Inorganic materials 0.000 abstract 1
- 150000008045 alkali metal halides Chemical class 0.000 abstract 1
- 229910001615 alkaline earth metal halide Inorganic materials 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 1
- 230000007574 infarction Effects 0.000 abstract 1
- 239000007942 layered tablet Substances 0.000 abstract 1
- 229910003002 lithium salt Inorganic materials 0.000 abstract 1
- 159000000002 lithium salts Chemical class 0.000 abstract 1
- MYUGVHJLXONYNC-UHFFFAOYSA-L magnesium diglutamate Chemical compound [Mg+2].OC(=O)C(N)CCC([O-])=O.OC(=O)C(N)CCC([O-])=O MYUGVHJLXONYNC-UHFFFAOYSA-L 0.000 abstract 1
- 235000013918 magnesium diglutamate Nutrition 0.000 abstract 1
- 239000004240 magnesium diglutamate Substances 0.000 abstract 1
- -1 magnesium halide Chemical class 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000003182 parenteral nutrition solution Substances 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 239000000741 silica gel Substances 0.000 abstract 1
- 229910002027 silica gel Inorganic materials 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 abstract 1
- 229910001631 strontium chloride Inorganic materials 0.000 abstract 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 150000005846 sugar alcohols Polymers 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752507354 DE2507354A1 (de) | 1975-02-20 | 1975-02-20 | Pharmazeutische zubereitung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1498913A true GB1498913A (en) | 1978-01-25 |
Family
ID=5939402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB6422/76A Expired GB1498913A (en) | 1975-02-20 | 1976-02-18 | Magnesium-containing pharmaceutical compositions |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4041154A (cg-RX-API-DMAC7.html) |
| DE (1) | DE2507354A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2301244A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1498913A (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2720288C2 (de) * | 1977-05-05 | 1984-02-16 | Verlapharm v. Ehrlich AG, Emmenbrücke | Verwendung von Magnesiumsalzen zur Herstellung von Zubereitungen zur Behandlung von Nutztieren |
| US4196196A (en) * | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
| AU599567B2 (en) * | 1984-03-01 | 1990-07-26 | Vernon Erk | Method of treating memory disorders of the elderly |
| JPS61501570A (ja) * | 1984-03-01 | 1986-07-31 | ア−ク，バ−ノン | 脊椎動物および他の生体内におけるアミンの酸化速度を変化させる方法 |
| FR2673512B1 (fr) * | 1991-03-05 | 1993-08-20 | Inst Rech Biolog Sa | Nouvelles compositions dietetiques a base de lipides complexes phosphores et leur utilisation dans les troubles du sommeil. |
| TW538153B (en) * | 1998-03-03 | 2003-06-21 | Heberlein Fibertechnology Inc | Process for air-jet texturing of frill yarn and yarn-finishing device and the application thereof |
| DE19809600C1 (de) * | 1998-03-03 | 1999-10-21 | Heberlein Fasertech Ag | Garnbehandlungseinrichtung |
| DE19830310A1 (de) * | 1998-07-07 | 2000-01-13 | Riedel De Haen Gmbh | Verfahren zur Abreicherung des Bromidgehaltes aus einer wäßrigen Bromid enthaltenden Lösung unter Verwendung von Wasserstoffperoxid |
| US6579905B1 (en) | 2001-11-19 | 2003-06-17 | Mcmains Michael B. | Method for the prevention or treatment of hypomagnesemia in pediatric patients and in patients with G-tubes or NG-tubes |
| RU2192259C1 (ru) * | 2001-11-27 | 2002-11-10 | Железнякова Ольга Викторовна | Йодсодержащая композиция |
| US11369630B1 (en) * | 2018-10-31 | 2022-06-28 | Flex-It Mg Llc | Formulations of magnesium chloride to treat muscle spasm, strain and sprain |
| US12370211B2 (en) | 2018-10-31 | 2025-07-29 | Flex—It Mg Llc | Formulations of magnesium chloride to treat muscle spasm, strain and sprain |
| KR20220003519A (ko) * | 2019-03-26 | 2022-01-10 | 윈산토르, 아이엔씨. | 말초 신경병증 치료를 위한 국소 제형 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3836668A (en) * | 1960-12-27 | 1974-09-17 | Ferrer Labor | Therapeutic composition and method of treating patients therewith |
| GB1141633A (en) * | 1965-02-27 | 1969-01-29 | Serono Ist Farm | Improvements in or relating to aspartic acid derivatives |
| US3674882A (en) * | 1968-05-17 | 1972-07-04 | Sandoz Ag | Dichloro trifluoromethyl phenyl lithium |
| US3778505A (en) * | 1970-12-01 | 1973-12-11 | Rech Etudes Therapeutiques Soc | Lithium salt based pharmaceutical composition and methods of use |
-
1975
- 1975-02-20 DE DE19752507354 patent/DE2507354A1/de active Pending
-
1976
- 1976-02-17 US US05/658,717 patent/US4041154A/en not_active Expired - Lifetime
- 1976-02-18 GB GB6422/76A patent/GB1498913A/en not_active Expired
- 1976-02-19 FR FR7604627A patent/FR2301244A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2507354A1 (de) | 1976-09-09 |
| FR2301244B1 (cg-RX-API-DMAC7.html) | 1979-07-20 |
| FR2301244A1 (fr) | 1976-09-17 |
| US4041154A (en) | 1977-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU563842B2 (en) | Omeprazole salts | |
| IL85277A0 (en) | Anhydrous,crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide and its preparation | |
| IL78858A0 (en) | Imidazole analogs of mevalonolactone and derivatives thereof,their preparation and pharmaceutical compositions containing them | |
| US4041154A (en) | Magnesium-containing pharmaceutical compositions | |
| AU586410B2 (en) | New cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions | |
| US3857939A (en) | Chewable sodium-free vitamin c tablets | |
| ES478272A1 (es) | Un procedimiento para la preparacion de una solucion acuosa esteril y estable de cisplatina. | |
| DE2965732D1 (en) | Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition | |
| DE3463050D1 (en) | Novel penem compounds, pharmaceutical compositions containing them, processes for their preparation | |
| IE832939L (en) | Pharmaceutical composition. | |
| GB1097074A (en) | Guanidine derivatives and compositions containing the same | |
| ES2009930A6 (es) | Mejoras en la patente de invencion 537.819 por procedimiento para anchoar. | |
| PT84885A (en) | Process for the preparation of ion mixed salts of monofluorinephosphate with aminoacids and sodium chloride and of pharmaceutical compositions containing them | |
| SU577715A1 (ru) | Инсектицидный гранулированный или порошкообразный препарат | |
| GR82094B (cg-RX-API-DMAC7.html) | ||
| GB1333010A (en) | Pharmaceutical compositions containing lithium | |
| TH5445A (th) | ผลิตภัณฑ์สำหรับช่องปาก |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19940218 |